Back

Placentrex disrupts the biofilm formation of Pseudomonas aeruginosa through multi-target transcriptional reprogramming.

Biju, B.; AJITH, T.; Sawant, A. R.; Maji, S.; Datta Chakraborty, P.; Neogi, T.; Ghosh, A. S.

2026-05-22 microbiology
10.64898/2026.05.22.727083 bioRxiv
Show abstract

AimsPseudomonas aeruginosa biofilm-associated infections pose a significant clinical challenge due to their inherent antibiotic tolerance. This study aimed to evaluate the antibacterial and antibiofilm activity of Placentrex, a standardised aqueous placental extract, against P. aeruginosa and to elucidate its molecular mechanism of action using RNA sequencing (RNA-seq). Methods and ResultsPlacentrex exhibited potent bactericidal activity against P. aeruginosa at 50 mg/mL. Biofilm formation was significantly inhibited by [~]87% at 50mg/mL after 72 hours. Preformed biofilms were eradicated by [~]93% and [~]89% at 50 and 25 mg/mL, respectively. Interestingly, biofilm viability was reduced by [~]93% and [~]87% upon treatment with 50 mg/mL and 25 mg/mL of Placentrex, respectively. EPS characterisation revealed that the EPS contain a single large polysaccharide, and chromatography data suggested that it is made up of glucose as a monomer. RNA-seq identified coordinated downregulation of seven key genes, namely, flp major pilin (surface attachment), extracellular solute binding protein (ABC transporter-mediated nutrient sensing and biofilm maintenance), gntP permease (carbon metabolism), AraC family transcriptional regulator (quorum sensing and polysaccharide biosynthesis), ureE (urease nickel metallochaperone), aromatic amino acid permease (pyoverdine and PQS biosynthesis), and MFS transporter (efflux and autoinducer export). ConclusionsPlacentrex exerts comprehensive antibiofilm and antibacterial activity through simultaneous disruption of surface attachment, nutrient-sensing-driven biofilm maintenance, quorum sensing, carbon metabolism, urease virulence maturation, and efflux-mediated persistence. This polypharmacological mechanism supports Placentrex as a promising multi-target antibacterial agent against P. aeruginosa biofilm-associated infections. Impact statementPlacentrex is a potential anti-biofilm agent against Pseudomonas aeruginosa.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Antibiotics
32 papers in training set
Top 0.1%
12.7%
2
Biofilm
15 papers in training set
Top 0.1%
10.1%
3
npj Biofilms and Microbiomes
56 papers in training set
Top 0.2%
8.4%
4
Microbiology Spectrum
435 papers in training set
Top 0.1%
8.2%
5
Journal of Global Antimicrobial Resistance
15 papers in training set
Top 0.1%
6.3%
6
mSystems
361 papers in training set
Top 2%
4.9%
50% of probability mass above
7
mBio
750 papers in training set
Top 4%
3.6%
8
Scientific Reports
3102 papers in training set
Top 45%
2.6%
9
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.8%
2.4%
10
PLOS ONE
4510 papers in training set
Top 48%
2.1%
11
Frontiers in Microbiology
375 papers in training set
Top 4%
2.1%
12
ACS Infectious Diseases
74 papers in training set
Top 0.5%
2.1%
13
Journal of Medical Microbiology
20 papers in training set
Top 0.2%
2.1%
14
Microbiology
57 papers in training set
Top 0.6%
1.7%
15
mSphere
281 papers in training set
Top 3%
1.7%
16
Water Research
74 papers in training set
Top 0.9%
1.7%
17
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 3%
1.5%
18
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.5%
19
PLOS Pathogens
721 papers in training set
Top 7%
1.3%
20
International Journal of Antimicrobial Agents
15 papers in training set
Top 0.4%
1.2%
21
Nature Communications
4913 papers in training set
Top 59%
0.9%
22
ACS Omega
90 papers in training set
Top 3%
0.9%
23
Journal of Applied Microbiology
18 papers in training set
Top 0.5%
0.7%
24
Infection and Immunity
103 papers in training set
Top 0.7%
0.7%
25
BMC Microbiology
35 papers in training set
Top 1%
0.7%
26
Applied and Environmental Microbiology
301 papers in training set
Top 3%
0.7%
27
Microbial Biotechnology
29 papers in training set
Top 0.9%
0.7%
28
Journal of Visualized Experiments
30 papers in training set
Top 1.0%
0.6%